Palvella Therapeutics (PVLA) Retained Earnings: 2013-2024
Historic Retained Earnings for Palvella Therapeutics (PVLA) over the last 11 years, with Sep 2024 value amounting to -$326.3 million.
- Palvella Therapeutics' Retained Earnings fell 5.13% to -$326.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$326.3 million, marking a year-over-year decrease of 5.13%. This contributed to the annual value of -$76.3 million for FY2023, which is 73.73% up from last year.
- Palvella Therapeutics' Retained Earnings amounted to -$326.3 million in Q3 2024, which was down 0.89% from -$323.4 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Retained Earnings ranged from a high of -$76.3 million in Q4 2023 and a low of -$326.3 million during Q3 2024.
- Its 3-year average for Retained Earnings is -$278.8 million, with a median of -$299.6 million in 2023.
- In the last 5 years, Palvella Therapeutics' Retained Earnings dropped by 26.48% in 2021 and then soared by 73.73% in 2023.
- Over the past 5 years, Palvella Therapeutics' Retained Earnings (Quarterly) stood at -$211.4 million in 2020, then declined by 21.64% to -$257.1 million in 2021, then decreased by 12.94% to -$290.4 million in 2022, then skyrocketed by 73.73% to -$76.3 million in 2023, then dropped by 5.13% to -$326.3 million in 2024.
- Its Retained Earnings stands at -$326.3 million for Q3 2024, versus -$323.4 million for Q2 2024 and -$319.9 million for Q1 2024.